Peptides for Veteran Pain? H.R. 10212 Bill Status and Evidence

If you saw the Bay News 9 story and wondered whether peptides could help veterans with chronic pain, here is the short answer. H.R. 10212, the PEPTIDES for Veterans Act, would ask the Department of Veterans Affairs to review peptide rules and study peptide-based therapies, including for chronic pain. It is still a bill. Rep. Nancy Mace introduced it on Sept. 1, 2026, and it has been referred to a House subcommittee. No source shows peptides work for veteran pain.

Disclosure: Heads up, some links on this page are affiliate links. If you buy through one of them, this site may earn a commission. This costs you nothing extra.

What is H.R. 10212, and what would it do?

H.R. 10212 is a bill in the U.S. House of Representatives. Its long title says it is meant “to study the potential benefits of peptide-based therapies for veterans receiving care through the Department of Veterans Affairs.” Congress.gov, the federal record of bills, lists the details below.

What steps would the bill require?

The bill sets out three steps, in order: a review, a study, and then a possible pilot.

Step 1: The review, within 180 days

After enactment, the VA Secretary would review the regulations and guidance on peptides. The Secretary would also set a definition of “peptide” for the purposes of the Act. A report to Congress would be due within 180 days, covering the existing rules, research developments, and the reasons behind the definitions.

Step 2: The study, within 18 months

Once that report is submitted, the VA would study the safety, efficacy and potential therapeutic benefits of peptide-based therapies for veterans receiving care at VA medical facilities. The study would look at possible uses for “recovery, rehabilitation, chronic pain, mental health, physical wellness, and other service-connected conditions.” It would also consider “the extent to which peptides are safe to use.” The study would need to finish within 18 months of the review report.

Step 3: The pilot, only if the study supports it

A pilot would happen only if the VA determines in its report that peptide-based therapies should be provided. Only veterans who elect to participate would join. The pilot would have to be completed within five years of being established, and a final report would describe “the effectiveness of peptide treatments” and which conditions improved.

Rep. Mace’s own press release, titled “Rep. Nancy Mace Introduces Bill To Expand Access To Cutting-Edge Peptide Therapies For Veterans,” describes the same steps. The headline is the sponsor’s framing. The bill text is the document to read for what the steps are.

What is the status of the bill right now?

H.R. 10212 was introduced on Sept. 1, 2026. On Sept. 8, 2026, it was referred to the Subcommittee on Health of the House Committee on Veterans’ Affairs. Congress.gov lists no cosponsors. Bay News 9 reported that the bill is still pending committee review.

H.R. 10212 has not passed the House or Senate and is not law, as Congress.gov shows. To watch for changes, check the Congress.gov record for H.R. 10212 and look at the “Actions” list.

What did the veteran and the doctor in the news story say?

The Bay News 9 report, published Nov. 11, 2026, quoted a veteran and a physician.

The veteran’s account

Kevin Cochie, 56, spent 20 years in the Army, much of it flying special-operations helicopters. He cites problems with his upper and lower spine, knee and shoulder. He said he had relied heavily on medication before he turned to peptides. He told Bay News 9 he was “shocked at how fast it helped my joint pain.” He said his lower back pain improved: “Not in total, but it went away significantly to where I could increase the intensity of my workout.” He supports the bill: “I absolutely think that peptides should be studied more because we have people using them.” He also said the VA “has been pretty positive” in recent years about looking at nonstandard therapies for pain.

The physician’s concerns

Dr. Patrick Mularoni, a sports and emergency medicine physician at Johns Hopkins All Children’s Hospital, spoke about peptides bought online. He said: “You are taking the risk that you’re getting what they say it is, that it’s not contaminated, and then no one’s actually studied it.” He added: “And we don’t know what the side effects are.” About FDA approval, he said: “This is the reason why we have FDA approval, so that these drugs can go through testing so that they can be tested on small groups and large groups looking at side effects.” On self-injection, he said: “There’s risks of local infections. There’s risks of contaminated needles.”

The sponsor and the industry voice

Rep. Nancy Mace, speaking for her own bill in her press release, said: “The VA shouldn’t bury promising advancements in bureaucracy simply because they’re new. Study it. Test it. Follow the evidence. If it works, veterans deserve access.”

Stars and Stripes, in its Sept. 28, 2026 article, quoted Jay Campbell, co-founder of BioLongevity Labs. That company manufactures “research-grade” peptides. Campbell said “peptides are not snake oil or a fringe wellness trend.” He called the bill “interesting because, at least in theory, it directs the VA to conduct an in-depth clinical study on peptide efficacy, independent of a commercial profit motive.”

Can peptides heal or ease chronic pain?

No source shows peptides work for veteran pain. What the bill does is ask the VA to study peptides, including for chronic pain. That is a request for research, and the results of that research would come later.

It helps to know what chronic pain is. The MedlinePlus chronic pain overview, from the U.S. National Library of Medicine, says chronic pain “lasts longer than three months or the time in which you should have healed.” It also says: “Treatment may not get rid of chronic pain, but it can help with your symptoms.” Its listed treatments include medicines, such as pain relievers, and non-drug treatments such as acupuncture, physical therapy, and sometimes surgery.

If you are still working out how to describe your pain, pain terms explained covers the difference between acute, persistent and chronic pain in plain language.

Which peptides are FDA-approved?

Stars and Stripes reported that some peptides, such as insulin and GLP-1 drugs, are approved by the Food and Drug Administration. It also reported that many other popular peptides sold online have not undergone clinical studies, according to Johns Hopkins Medicine. Bay News 9 reported that many peptides, including those Cochie said he takes, are not approved by the FDA.

Bay News 9 also reported that the FDA has raised concerns about “potential immune reactions, quality control and insufficient human safety information involving many unregulated peptides.” For a broader look at how peptide safety is studied, see peptides safety evidence (our research library).

What does VA care look like right now?

Stars and Stripes reported that the VA covers GLP-1 drugs for veterans with certain medical conditions, including obesity with heart disease, Type 2 diabetes and obstructive sleep apnea. It also reported that the VA launched a large study in July that looks at semaglutide, a GLP-1 drug, for alcohol addiction in veterans. Participants receive semaglutide or a placebo, which is an inactive comparison, for 24 weeks. That study is separate from H.R. 10212.

For the VA’s own position on H.R. 10212, ask your VA primary care team. They can also tell you which pain options are available to you now.

What are the common mix-ups?

Who would this bill affect?

The study would cover veterans receiving care at VA medical facilities. The pilot would cover only veterans who elect to take part, and only if the VA’s study supports it.

If you are a spouse, family member or caregiver, the pilot would still be the veteran’s choice. Your role is to help them bring questions to the VA team and to keep track of what they learn.

If you also have Medicare, the Medicare chronic pain coverage page says Part B covers chronic pain management and treatment services if you are eligible. Eligibility requires chronic pain lasting longer than 3 months. You pay 20% of the Medicare-approved amount after the Part B deductible. Services may include pain assessment, medication management, and care coordination and planning.

What are the key dates?

What should I ask at a VA or pain-care visit?

Bring your current medicine list, and keep a short record of where your pain is, how long it lasts, and what has helped. your medication list for a pain-care visit lists what to bring. Ask these questions:

• Does the VA offer any peptide-based therapy for chronic pain today? If so, which ones?
• Which peptide am I asking about, and is it FDA-approved for any use?
• If I found a product online, how would I know what is in it and where it came from?
• Which side effects should I watch for, and who should I contact if I notice one?
• What other pain options fit my situation, and what would each cost me?
• Would a team with several specialists help? Ask about what does multidisciplinary pain care mean in your clinic.

You can use this wording at your visit: “I read about H.R. 10212 on peptides for veterans. What does the VA say about peptides for my pain, and what options are available to me now?”

What is the next small step?

Book a visit with your VA primary care team and bring your medicine list and your questions. Then check the Congress.gov record for H.R. 10212 in a few weeks to see whether any new action has been recorded.

By the Pain Care Questions Team

This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.

Read next

• Activity Pacing With Chronic Pain
• Chronic Pain Study Outcomes